Top compounds associated with response to EXTL2


Feature Type Standardized
Nominal ANOVA
mRNA Talazoparib GDSC1000 pan-cancer AAC 0.1 0.005
mRNA PD 153035 CTRPv2 pan-cancer AAC -0.13 0.005
mRNA SID 26681509 CTRPv2 pan-cancer AAC 0.12 0.005
mRNA Nilotinib CCLE pan-cancer AAC 0.15 0.005
mRNA JNK Inhibitor VIII GDSC1000 pan-cancer AAC -0.11 0.005
mRNA SR-II-138A CTRPv2 pan-cancer AAC 0.096 0.006
mRNA ML311 CTRPv2 pan-cancer AAC 0.097 0.006
mRNA lapatinib GDSC1000 pan-cancer AAC -0.15 0.006
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.007
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.007
Download CSV